where is glp 1 produced Glucagon-like peptide-1: Trends in Endocrinology & Metabolism Current Insights, Advantages and Challenges
Description
The drug was initially approved by the U.S
Lancet (2015) 386(9996):896912
Febs Letters, 393 ,
Meanwhile, an observational study published in May suggests that people with Type 2 diabetes who take a GLP-1 (like Mounjaro) may have an increased risk of developing NAION
In fact, a very sophisticated type of spectroscopy is required to tell one from the other
